[1]邱蔚六.口腔颌面外科理论与实践[M].北京:人民卫生出版社,1998:565-567[2]候德强,陈东,焦晓辉,等.妊娠中期因子和CD105在人舌鳞状细胞癌中的表达和意义的研究[J].口腔医学,2011,8(31):459-462[3]Kos J,Kraovec M,Cimerman N,et al.Cysteine proteinase inhibitorsstefin A,stefin B,and cystatin C in sera from patients with colorectal cancer: relation to prognosis[J][J].Clin Cancer Res,2000,6(2):505-511[4]Coulibaly S,Schwihla H,Abrahamson M,et al.Modulation of invasive properties of murine squamous carcinoma cells of heterologous expression of cathepsin B and cystatin C[J].Int J Cancer,1999,83(4):526-531[5]Mussap M,Plebani M.Biochemistry and clinical role of human cystatin C[J].Crit Rev Clin Lab Sci,2004,41(5-6):467-550[6]Ray S,Lukyanov P,Ochieng J.Members of the cystatin super family in teract with MM P-9 and protect it from autolytic degradation without affecting its gelatinolytic activities[J].Biochim Biophys Acta,2003,1652(2):91-102[7]王素梅,李力,张玮,等.组织蛋白酶B及其组织抑制剂在卵巢恶性肿瘤组织中表达及其意义的研究[J].中华肿瘤防治杂志,2008,15(5):363-366[8]黄伟刚,陈荣策,陈福佳.结直肠癌患者血清半胱氨酸蛋白酶抑制剂C的变化及临床意义[J].医学研究杂志,2008,37(12):91-92[9]Nishikawa H,Ozaki Y,Nakanishi T,et al.The role of cathepsin B and Cystatin C in the mechanisms of invasion by ovarian cancer[J].Gynecol Oncol,2004,92(3):881-886[10]肖蓉.多发性骨髓瘤患者血清胱抑素C水平测定[J].华西医学,2012,27(2):171-173[11]徐春华,于力克.非小细胞肺癌患者血清半胱氨酸蛋白酶抑制剂C的变化及意义[J].中国呼吸与危重监护杂志,2011,10(4):384-385[12]Ritonja A,Machleidt W,Barrett AJ.Amino acid sequence of the intracellular cysteine proteinase inhibitor cystatin B from human liver[J].Biochem Biophys Res Commun,1985,131(3):1187-1192[13]Ebert E,Werle B,Jülke B,et al.Expression of cysteine protease inhibitors stefin A,stefin B,and Cystain C in human lung tumor t2[J].Adv Exp Med Biol,1997,421(2):259-265[14]Lee MJ,Yu GR,Park SH,et al.Identification of cystatin B as a potential serum marker in hepatocellular carcinoma[J].Clin Cancer Res,2008,14(4):1080-1089 |